Compare Stocks

Black Knight, Inc. provides integrated software, data, and analytics solutions in North America and Internationally. The company operates in two segments, Software Solutions and Data and Analytics. The Software Solutions segment offers software and hosting solutions, including MSP, a software as a service application platform for mortgage, home equity loans, and lines of credit; Servicing Digital, a web and mobile solution for consumers that provides access to customized timely information about their mortgages; Loss Mitigation, an integrated solution that supports retention and liquidation workouts to streamline the loss mitigation process and reduce risk; and Empower, a loan origination system used by lenders to originate mortgages, home equity lines of credit, and supporting retail, consumer-direct, home equity, correspondent, wholesale and assumption channels on a single, and unified platforms. This segment also provides LoanCatcher, a cloud-based loan origination system designed for the needs of brokers; and LoanSifter PPE to meet the needs of the broker community by providing access to investors and loan products. The Data and Analytics segment offers property ownership data, lien data, servicing data, automated valuation models, collateral risk scores, behavioural models, lead generation, multiple listing service, and other data solutions. The company was formerly known as Black Knight Financial Services, Inc. and changed its name to Black Knight, Inc. in October 2017. Black Knight, Inc. was founded in 2013 and is headquartered in Jacksonville, Florida.

Cornerstone Capital Resources Inc., through its subsidiaries, engages in the acquisition, evaluation, and exploration of mineral properties in Ecuador and Chile. The company primarily explores for gold, copper, and silver deposits. Its flagship project is the Cascabel project located in northern Ecuador. The company was founded in 1997 and is based in Ottawa, Canada.

Hospira, Inc. provides injectable pharmaceutical drugs and infusion technologies and it develops, manufactures, distributes and markets biosimilars. The Company's portfolio includes generic acute-care and oncology injectables, biosimilars, and integrated infusion therapy and medication management products. The Company conducts operations across the world and is managed in three segments: the Americas, which include the United States, Canada, and Latin America; Europe, Middle East, and Africa (EMEA), and the Asia Pacific, which includes Asia, Japan, Australia and New Zealand. Its portfolio of products includes Specialty Injectable Pharmaceuticals, which includes generic injectables, injectables and biosimilars, Medication Management and Other Pharmaceuticals. Its portfolio of products is used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities.